Preoperative Multistrain Probiotic Supplementation Does Not Affect Body Weight Changes or Cardiometabolic Risk Factors in Bariatrics: Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Nutrients · 2024
DOI: 10.3390/nu16132055 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Marta Potrykus und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncological, Transplant, and General Surgery, Medical University of Gdansk, 80-211 Gdańsk, Poland. Hauptthemen laut MEDLINE: Probiotics, Bariatric Surgery, Weight Loss. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Emerging evidence suggests that microbiota plays a crucial role in the development, progression, and therapeutic options in obesity and its comorbidities. This study assessed preoperative probiotic therapy’s impact on bariatric treatment outcomes. A 12-week randomized, double-blind, placebo-controlled trial with 48 patients undergoing bariatric surgery was conducted. Participants received probiotics—Sanprobi Barrier—which contained nine strains of bacteria: Bifidobacterium bifidum W23, Bifidobacterium lactis W51 and W52, Lactobacillus acidophilus W37, Levilactobacillus brevis W63, Lacticaseibacillus casei W56, Ligilactobacillus salivarius W24, Lactococcus lactis W19, and Lactococcus lactis W58. Primary outcomes included excess body weight loss, body weight loss, and excess body mass index loss, with secondary objectives focusing on metabolic profiles. Surgical treatment of obesity significantly improved anthropometric and metabolic parameters. No significant differences were observed in primary outcomes or in secondary outcomes between groups at any time point post-surgery. Preoperative probiotics administration did not affect clinical outcomes 1, 3, or 6 months following bariatric surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncological, Transplant, and General Surgery, Medical University of Gdansk, 80-211 Gdańsk, Poland.
- Department of Clinical Nutrition and Dietetics, Medical University of Gdansk, 80-211 Gdańsk, Poland.
- Sanprobi sp. z o.o. sp. k., 70-535 Szczecin, Poland.
- Department of Biochemical Science, Pomeranian Medical University in Szczecin, 71-460 Szczecin, Poland.
- Independent Public Health Care Center of the Ministry of Internal Affairs and Administration, 80-210 Gdańsk, Poland.
ORCID-Profile: Marta Potrykus, Sylwia Czaja-Stolc, Michał Szymański
Zitieren
APA
Potrykus, M., Czaja-Stolc, S., Stankiewicz, M., Szymański, M., Łoniewski, I., Kaska, Ł., & Proczko-Stepaniak, M. (2024). Preoperative Multistrain Probiotic Supplementation Does Not Affect Body Weight Changes or Cardiometabolic Risk Factors in Bariatrics: Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Nutrients. https://doi.org/10.3390/nu16132055
Vancouver
Potrykus M, Czaja-Stolc S, Stankiewicz M, Szymański M, Łoniewski I, Kaska Ł, et al. Preoperative Multistrain Probiotic Supplementation Does Not Affect Body Weight Changes or Cardiometabolic Risk Factors in Bariatrics: Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Nutrients. 2024. doi:10.3390/nu16132055
BibTeX
@article{Potrykus2024,
author = {Potrykus, Marta and Czaja-Stolc, Sylwia and Stankiewicz, Marta and Szymański, Michał and Łoniewski, Igor and Kaska, Łukasz and Proczko-Stepaniak, Monika},
title = {Preoperative Multistrain Probiotic Supplementation Does Not Affect Body Weight Changes or Cardiometabolic Risk Factors in Bariatrics: Randomized, Double-Blind, Placebo-Controlled Clinical Trial},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16132055}
}
EUVIMED